Securities Firm Looks into Fraud at Cooper

The securities firm Faruqi & Faruqi, LLP, is investigating whether Cooper and its officers violated federal securities laws by failing to disclose what a Faruqi press release called "the true significance of its product recall." In August 2011, the company commenced a “limited voluntary” recall of its Avaira Toric line of contact lenses. Faruqi's press release stated that at that time, Cooper intentionally downplayed the breadth and impact of its quality control problems. On November 15, 2011, Cooper expanded its recall. Shortly thereaftrer, the company’s stock price fell. Request more information now by clicking here: www.faruqilaw.com/COO.

The Cleveland.InjuryBoard.com reports that "as the recall of Avaira contact lenses has been expanded, reports of adverse symptoms have also increased. Individuals who used Avaira Toric or Avaira Sphere contact lenses continue to report adverse events to CooperVision, as well as to their doctors, lawyers, and the FDA. There are increasing reports of serious eye injuries including corneal ulcers, corneal lesions, corneal abrasions, corneal edema, corneal erosion, and keratitis." Read more.